Role of carbonic anhydrase IX expression in prediction of the efficacy and outcome of primary epirubicin/tamoxifen therapy for breast cancer
Daniele Generali(University of Trieste), Adrian L. Harris(University of Oxford), Alberto Bottini(University of Genoa), Paolo Bruzzi(Alleanza Contro il Cancro), Alessandra Bersiga(Istituti Ospitalieri di Cremona), Giovanni Allevi(Istituti Ospitalieri di Cremona), Maria Pia Brizzi(Ospedale San Luigi Gonzaga), Sergio Aguggini(Istituti Ospitalieri di Cremona), Luigi Dogliotti(Aarhus University Hospital), Stephen B. Fox(Peter MacCallum Cancer Centre), Manuela Milani(Humanitas University), Simone Bonardi(Istituti Ospitalieri di Cremona), Alfredo Berruti(Surgical Specialties (Canada)), Leticia Campo(University of Oxford), Simon Wigfield(John Radcliffe Hospital)
Cited by 79
Related Papers
Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study
|Journal of Clinical Oncology|2000|2.3k
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
|Proceedings of the National Academy of Sciences|2003|2k